PTK2 and adenocarcinoma: This catalyst-like impact of JQ1 on tumor cell sensitivity to VS-6063 was in line with our recent study of another epithelia-originating cancer (Xu et al., 2017), even though the co-amplification of FAK and c-Myc rarely occurs in human NSCLC adenocarcinomas.